Special Issue "Protein Kinase Inhibitors"

Quicklinks

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (20 December 2012)

Special Issue Editor

Guest Editor
Prof. Dr. Lee M. Graves
Department of Pharmacology, University of NC at Chapel Hill, Genetic Medicine Building, Room 4111, CB# 7365120 Mason Farm Road, Chapel Hill, NC, 27599-7365, USA
Website: http://www.med.unc.edu/pharm/people/primaryfaculty/lee-m-graves-1/lee-m-graves
E-Mail: lmg@med.unc.edu
Interests: protein phosphorylation and protein kinase-mediated signaling pathways; application of proteomics; protein kinase inhibitors as therapeutics; regulation of metabolic enzymes by phosphorylation and interacting proteins

Keywords

  • p38 MAP kinase
  • Erk
  • Jnk
  • Raf
  • BCR-Abl,p70 S6 kinase
  • mTor
  • Pyk2
  • Protein Kinase CK2

Published Papers (11 papers)

Pharmaceuticals 2013, 6(6), 716-727; doi:10.3390/ph6060716
Received: 14 January 2013; in revised form: 1 May 2013 / Accepted: 8 May 2013 / Published: 27 May 2013
Show/Hide Abstract | PDF Full-text (182 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2013, 6(3), 407-439; doi:10.3390/ph6030407
Received: 11 December 2012; in revised form: 12 March 2013 / Accepted: 13 March 2013 / Published: 21 March 2013
Show/Hide Abstract | PDF Full-text (548 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2010, 3(7), 2111-2145; doi:10.3390/ph3072111
Received: 9 April 2010; in revised form: 3 June 2010 / Accepted: 23 June 2010 / Published: 5 July 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (683 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2010, 3(7), 2045-2058; doi:10.3390/ph3072045
Received: 23 April 2010; in revised form: 24 May 2010 / Accepted: 24 June 2001 / Published: 2 July 2010
Show/Hide Abstract | Cited by 1 | PDF Full-text (195 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2010, 3(6), 1842-1872; doi:10.3390/ph3061842
Received: 31 March 2010; in revised form: 13 May 2010 / Accepted: 26 May 2010 / Published: 4 June 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (667 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2010, 3(6), 1739-1760; doi:10.3390/ph3061739
Received: 8 April 2010; in revised form: 26 April 2010 / Accepted: 24 May 2010 / Published: 26 May 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (3244 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2010, 3(5), 1576-1593; doi:10.3390/ph3051576
Received: 1 April 2010; in revised form: 26 April 2010 / Accepted: 11 May 2010 / Published: 18 May 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (127 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2010, 3(5), 1446-1455; doi:10.3390/ph3051446
Received: 26 March 2010; in revised form: 20 April 2010 / Accepted: 11 May 2010 / Published: 12 May 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (117 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2010, 3(5), 1311-1334; doi:10.3390/ph3051311
Received: 31 March 2010; in revised form: 12 April 2010 / Accepted: 19 April 2010 / Published: 28 April 2010
Show/Hide Abstract | Cited by 12 | PDF Full-text (240 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2010, 3(4), 1225-1231; doi:10.3390/ph3041225
Received: 9 March 2010; in revised form: 21 April 2010 / Accepted: 22 April 2010 / Published: 22 April 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (169 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2010, 3(1), 42-58; doi:10.3390/ph3010042
Received: 23 October 2009; in revised form: 3 December 2009 / Accepted: 5 January 2010 / Published: 7 January 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (366 KB) | HTML Full-text | XML Full-text

Last update: 4 March 2014

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert